Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Eoganachton Aug 13, 2024 1:28pm
216 Views
Post# 36176899

RE:RE:RE:RE:RE:RE:SO IM MISSING THE GOOD NEWS

RE:RE:RE:RE:RE:RE:SO IM MISSING THE GOOD NEWSHi DJDawg - nice post. That all makes sense to me. I think it's possible the pending patients are ones for which Theralase has not yet received the post-450 day patient permission forms.

Your analysis sounds right to me. It's excitng to contemplate the possibility that 25% of all patients treated are cancer free at 3 years! Theralase will be able to claim that one quarter of all patents treated are cured of bladder cancer after 1 or 2 treatments


DJDawg wrote: The new swimmers is interesting in a few ways.

One thing that is new is that they are showing the dots and squares at the true time point date when happened. It makes sense that things never happen on the days exactly as there can be issues that arise. The explains why green dots and red squares are not a perfect line down at each time point.

Eog, I find the plot confusing in one way. The grey bars at the top represent a patient's path. The arrows are the end are indicating "ongoing response". Yet many of the grey bars have a series of Ps in them which is confusing. Pending as in there is more data needed? Pending as in we don't know if CR or NR at all. I don't think pending means that the CR status is in question since the text of the document indicates 17/41 are CR beyond 450 days. That math only works if you are counting the grey bars with P in them. So my guess is that the grey bar is CR that is known and the Pending is that they don't have the full data set (not sure why or what) on them.

So if you work off the assumption that a grey bar is CR even if it says P or green dot in particular then the numbers look very good. The one patient have disease recurrence at 810 days is very interesting and I suspect might even represent a de-novo cancer arising rather than return of the original after 27 months of being CR. Either way it is an anomaly. If you carry forward the CRs that are CR at 540 and assume all stay that way then the >3y rate will be almost 40%. If we are using the old math that would be 16/65 for a CR rate of nearly 25% at >3yrs.

Hope that makes sense and I have not erred.


<< Previous
Bullboard Posts
Next >>